BPPV diagnosis and treatment

Jing Hui; Qi Lei; Zhi Ji; Dingjing Zi

Improve Research Reproducibility A Bio-protocol resource

Home
Protocols

Concise Method

BPPV diagnosis and treatment

JH Jing Hui

QL Qi Lei

ZJ Zhi Ji

DZ Dingjing Zi

This method is extracted from research article: Biol Res, Apr 2022

Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway

DOI: 10.1186/s40659-022-00385-3

Request a Protocol

Ask a question

Favorite

After a thorough physical examination and a review of clinical history, each candidate underwent the supine head-turning test or Dix-Hallpike test. In most cases (about 90%), BPPV was involved with the posterior semicircular canal, and most patients were diagnosed with canalithiasis type. Thus, only the canalithiasis type of BPPV patients involved with the posterior semicircular canal in this study. Sixty patients who were included were randomly assigned to two groups. One group was treated with Betahistine (12 mg/time, 3 times/day); the other group was treated with placebo. This treatment was continued for 4 weeks. Blood samples were then drawn at the end of 4 weeks. All patients signed an informed consent form approved by the second affiliated hospital of air force medical university Institutional Review Board prior to the first blood sampling.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

Post a Question

0 Q&A

Share your protocol with your peers.

Submit a Preprint Protocol